Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Strategies for successful rapid trials of influenza vaccine.

Scheifele DW, Marty K, LaJeunesse C, Fan SY, Bjornson G, Langley JM, Halperin SA.

Clin Trials. 2011 Dec;8(6):699-704. doi: 10.1177/1740774511419868. Epub 2011 Sep 7.

PMID:
21900340
2.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.

3.
4.

Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Dec 25;58(50):1401-5.

5.
6.

Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population.

Redelings MD, Piron J, Smith LV, Chan A, Heinzerling J, Sanchez KM, Bedair D, Ponce M, Kuo T.

Vaccine. 2012 Jan 5;30(2):454-8. doi: 10.1016/j.vaccine.2011.10.050. Epub 2011 Oct 30.

PMID:
22044740
7.

Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.

Girard MP, Katz JM, Pervikov Y, Hombach J, Tam JS.

Vaccine. 2011 Oct 13;29(44):7579-86. doi: 10.1016/j.vaccine.2011.08.031. Epub 2011 Aug 19.

PMID:
21856358
8.

Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.

Banzhoff A, Haertel S, Praus M.

Hum Vaccin. 2011 May;7(5):539-48. Epub 2011 May 1.

PMID:
21422814
9.

Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.

Seale H, Kaur R, Wang Q, Yang P, Zhang Y, Wang X, Li X, Zhang H, Zhang Z, MacIntyre CR.

Vaccine. 2011 Feb 11;29(8):1605-10. doi: 10.1016/j.vaccine.2010.12.077. Epub 2011 Jan 4.

PMID:
21211593
10.

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA; Vaccine Safety Datalink Project.

Am J Prev Med. 2011 Aug;41(2):121-8. doi: 10.1016/j.amepre.2011.04.004.

PMID:
21767718
11.

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.

Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.

PMID:
19835828
12.

Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8.

13.

Pandemic influenza vaccination: will the health care system take its own medicine?

Ferguson CD, Ferguson TE, Golledge J, McBride WJ.

Aust J Rural Health. 2010 Aug;18(4):137-42. doi: 10.1111/j.1440-1584.2010.01148.x.

PMID:
20690908
14.

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients.

Esposito S, Meregalli E, Daleno C, Ghio L, Tagliabue C, Valzano A, Serra D, Galeone C, Edefonti A, Principi N.

Nephrol Dial Transplant. 2011 Jun;26(6):2018-24. doi: 10.1093/ndt/gfq657. Epub 2010 Oct 25.

15.

Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public.

Eastwood K, Durrheim DN, Jones A, Butler M.

Med J Aust. 2010 Jan 4;192(1):33-6.

PMID:
20047546
16.

Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.

Torun SD, Torun F.

Vaccine. 2010 Aug 9;28(35):5703-10. doi: 10.1016/j.vaccine.2010.06.049. Epub 2010 Jun 30.

PMID:
20600497
17.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.

López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, Arteaga-Ruiz O, Arriaga-Pizano L, Hickman SP, Allende M, Lenhard K, Pincus S, Connolly K, Raghunandan R, Smith G, Glenn G.

Vaccine. 2011 Oct 13;29(44):7826-34. doi: 10.1016/j.vaccine.2011.07.099. Epub 2011 Aug 2.

PMID:
21816199
18.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
19.

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.

Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rödler S, Rasoul-Rockenschaub S, Jaksch P, Redlberger-Fritz M, Popow-Kraupp T, Burgmann H.

Vaccine. 2011 Sep 16;29(40):6888-93. doi: 10.1016/j.vaccine.2011.07.050. Epub 2011 Jul 29.

PMID:
21803100
20.

Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial.

Uno S, Kimachi K, Kei J, Miyazaki K, Oohama A, Nishimura T, Ibaragi K, Odoh K, Kudo Y, Kino Y.

Microbiol Immunol. 2011 Nov;55(11):783-9. doi: 10.1111/j.1348-0421.2011.00381.x.

Items per page

Supplemental Content

Write to the Help Desk